Source link : https://www.newshealth.biz/health-news/which-patients-benefit-from-endocrine-therapy-past-5-years/
TOPLINE: Women with high-risk estrogen receptor–positive (ER-positive), human epidermal growth factor receptor 2–negative (HER2-negative) breast cancer may benefit from extending endocrine therapy beyond the standard 5 years, new research showed. METHODOLOGY: Patients with ER-positive, HER2-negative breast cancer typically receive endocrine therapy for 5 years, but some patients may benefit from an extended regimen. To address […]
Author : News Health
Publish date : 2024-02-12 08:00:25
Copyright for syndicated content belongs to the linked Source.